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Abstract 
For several decades, a multitude of studies have documented the ability of Raman spectroscopy (RS) to differentiate 
between tissue types and identify pathological changes to tissues in a range of diseases. Furthermore, 
spectroscopists have illustrated that the technique is capable of detecting disease-specific alterations to tissue before 
morphological changes become apparent to the pathologist. This study draws comparisons between the information 
that is obtainable using RS alongside immunohistochemistry (IHC); since histological examination is the current 
GOLD standard for diagnosing a wide range of diseases. Here, Raman spectral maps were generated using formalin-
fixed, paraffin-embedded colonic tissue sections from healthy patients and spectral signatures from principal 
components analysis (PCA) were compared with several IHC markers to confirm the validity of their localizations. 
PCA loadings identified a number of signatures that could be assigned to muscle, DNA and mucin glycoproteins and 
their distributions were confirmed with antibodies raised against anti-Desmin, anti-Ki67 and anti-MUC2 respectively. 
The comparison confirms that there is excellent correlation between RS and the IHC markers used, demonstrating 
that the technique is capable of detecting compositional changes in tissue in a label-free manner, eliminating the 
need for antibodies. 
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1 Introduction 
Raman spectroscopy (RS) is a vibrational 
spectroscopic technique that relies on inelastic 
scattering of light by polarizable molecules.  Raman 
scatter occurs when photons of a defined energy 
impinge on an analyte, leading to the emission of 
lower and higher energy photons, which are 
detected and provide information on the 
biochemical composition of cells, tissues and 
biofluids[1]. The method offers chemical detection, 
analysis and interpretation with minimal or no 
sample preparation as Raman is an optical 
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technique[2]. RS has been used to analyze biological 
samples for decades, but with recent advances in 
lasers, detectors and fibre optics along with 
improvements in spatial resolution and scan speed it 
is now feasible to implement Raman in a routine 
clinical setting for in vivo disease classification and 
diagnosis[3]. The fundamental principle underpinning 
these developments is that disease-related 
molecular changes in cells, tissues or biofluids can be 
reliably and reproducibly detected by RS and used as 
characteristic fingerprints[1]. Importantly, 
multivariate calibration and classification models can 
be applied to mine large spectral datasets in order to 
obtain quantitative and objective diagnoses in a 
range of diseases[4, 5]. RS therefore has the potential 
to be used for diagnostics, prognostics and as a tool 
for evaluating response to treatment. 
Colorectal cancer (CRC) is one of the most prevalent 
cancers in the developed world[6], but is also one of 
the most easily curable if detected at an early-
stage[7].  Genetic mutations cause CRCs and the 
disease is broadly categorized into hereditary and 
sporadic types, which have differing genetic 
causes[8]. In most cases the disease develops slowly 
and a number of CRCs remain asymptomatic for 
many years prior to diagnosis. Fecal occult blood 
testing is widely used to screen for CRC, but although 
the technique is cheap and inexpensive it is error-
prone in detecting CRCs[9]. Therefore patients with 
abnormal screening results are examined by 
colonoscopy and CRCs are routinely detected by 
visual inspection of suspicious lesions and polyps 
that are seen during the procedure. Suspicious 
tissues are removed during colonoscopy, stained 
with chemical dyes, and later inspected by a 
pathologist for any sign of cancer. This method can 
provide a basic diagnosis of cancer presence and 
stage, however simple visual inspection provides no 
information on the origin of the disease or disease-
associated genetic markers. This information is 
obtained by analysis of known cancer markers, for 
example genetic mutations must be uncovered using 
next generation sequencing and aberrations at the 
protein level with immunohistochemistry (IHC) 
respectively.   
Two of the most widely used groups of molecular 
markers are carcinoembryonic antigens and 
carbohydrate antigens[9]. The markers have been 
associated with cancer progression and prognosis[10, 
11]. Microsatellite instability has also been linked with 
a large fraction of colorectal cancers and these are 
identified using immunohistochemistry (IHC). IHC is 
widely used in pathology to detect disease-related 
tissue antigens via antigen-antibody binding. In colon 
cancers, the technique is used to detect MLH1 and 
MSH2, which are key proteins involved in DNA 
mismatch repair and a loss of these proteins is 
indicative of microsatellite instability[9]. IHC also 
plays an important role in the detection of mucinous 
tumors in colon, with most advanced colorectal 
tumors abnormally secreting mucins, linking 
mucinous tumors with poor survival rates[12]. 
However, these types of genetic analyses are not 
routinely performed due to their cost. Furthermore, 
IHC is a very powerful tool in CRC diagnosis because 
it provides pathologists with additional (spatial) 
morphological information which can be used in 
phenotyping tumors. IHC relies on the ability of 
target-specific antibodies to bind antigens on tissue 
sections. For detection purposes the antibody 
probes are commonly linked to reporter molecules.  
These alert the pathologist to the antibody binding 
locations on the tissue sample by their direct UV or 
visible emission/absorption spectra or capacity to 
deposit easily visible stains (chromogens).  Although 
extremely useful and well established in the field, 
IHC methods suffer a number of limitations when 
applied to tissue specimens. Firstly, the technique 
relies upon the availability of an antibody that 
specifically binds to an antigen of known interest. 
Once the appropriate antibody has been selected, 
staining is only reliable when samples are promptly 
fixed and reliably processed in order to maintain 
antigen viability[13]. The size of the tissue section 
available for staining is also of concern as small 
specimens are unsuitable for staining as the number 
of tumor cells may be below the detection limit and 
there may also be insufficient material available to 
confirm a positive result[9]. Staining is normally 
completed over a period of hours and protocols 
commonly implement a number of washing, blocking 
and incubation steps. The complex, multi-step 
nature of IHC staining also means that the reliability 
of results is governed by the experience of the 
operator performing staining, features of any 
automation used and quality of the antibodies; all of 
these features may contribute to variance in the 
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data and create significant bias[13]. Furthermore, 
since markers need to be pre-selected and 
demonstrated to correlate with disease the 
technique is not suitable for identifying general 
abnormalities. 
We are focusing on FFPE tissue blocks since these 
are the standard sample format utilized by pathology 
departments for IHC and other diagnostic tests. 
When working with FFPE issues, insufficient paraffin 
removal can lead to a number of known issues in 
both Raman and IHC. Firstly, paraffin peaks appear 
across the biological spectral region, showing 
distinctive Raman contributions around 1063 
cm-1, 1133 cm-1, 1296 cm-1, and 1441 cm-1[14]. 
Peaks in these regions can obscure a multitude of 
tissue peaks, negatively impacting feature 
detection[15]. For IHC paraffin not only physically 
blocks epitopes on the tissue surface, preventing 
antibody binding, but it can also trap excess 
chromogens, giving a false positive or high 
background signal[16]. It is therefore essential to 
implement thorough and reproducible 
deparafination procedures during tissue processing 
in order to minimize artifacts caused by paraffin 
contribution during analysis.  
RS has been applied to study tissue and cells for 
several decades and has proven that tissue, cell and 
disease-specific spectral signatures are attainable. 
Spectra are generated using Raman scatter from 
components of the genome, proteome and 
metabolome and are displayed as collections of 
overlapping peaks, which can be mined for the 
molecular information they contain. The ability to 
collect all of this data simultaneously, in a single 
spectrum, means that abnormalities can be detected 
rapidly through spectral differences.  For clinical 
application, spectral changes must be correctly 
assigned to the disease under investigation and this 
is routinely accomplished through classification 
algorithms. However, one major drawback to this 
methodology is the current failure of spectroscopists 
to validate their algorithms by reference to proven 
and accepted detection methods and therefore 
adoption of RS by clinicians has proved problematic. 
To validate the capabilities of RS to detect 
pathological changes here we correlate spectral 
features with clinically validated antibody 
localization and show that RS has the potential to, at 
least, complement current IHC methods in the CRC 
pathology workflow. Novel studies using surface 
enhanced RS alongside conventional IHC methods 
are now being implemented. Deemed immuno-RS, 
the method employs surface-enhanced Raman 
scattering from an immuno-Raman label in order to 
selectively detect disease-specific antigens with high 
sensitivity. The protocol has been previously 
described for PSA detection in prostate tissue with 
promising initial results[17]. Additionally, Raman 
microscopy has more recently been compared 
against IHC data in comparing EGFR mutation status 
in lung adenocarcinoma[18]. The study correlated IHC-
associated molecular changes with Raman spectral 
data and built an algorithm capable of diagnosing 
E19del and L858R mutations with an accuracy of 
87.8%. RS could overcome a number of current 
limitations in IHC workflows as it is capable of 
providing simultaneous detection of multiple 
antigens and their spatial distributions in the same 
tissue specimen, removing the need for multiple 
biopsies and antibody panels. The technique is also 
label-free and does not require expensive antibodies 
and dyes to detect antigens like in conventional IHC, 
reducing the cost of analysis.  
These studies have been made possible through 
advances in instrumentation and substrate 
development. Recent substrate developments have 
highlighted stainless steel as suitable, low-cost 
material for tissue analysis, substantially reducing 
the costs associated with Raman analysis of tissue[19]. 
Newly characterized substrates also exhibit 
improved signal to noise ratios over commonly used 
and expensive calcium fluoride, indicating that tissue 
spectra can be obtained at greater speeds [20]. 
Reduction in mapping costs and improvements in 
mapping speed now means that RS has reached the 
stage where it has the potential to be integrated into 
the pathology workflow. RS is objective and offers a 
very reliable diagnosis as it provides a biochemical 
fingerprint of the tissue under investigation and does 
not rely upon subjective assessment. Previous 
studies have combined RS with basic hematoxylin 
and eosin (H&E) staining and white light microscopy 
images [21-23], while this paper is the first of its kind to 
investigate the tissue morphological information 
that can be obtained in a direct comparison between 
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RS and IHC. Results clearly show the co-localization 
of spectral signatures with IHC staining and 
demonstrate the multiplexing capabilities of RS. 
 
2 Materials and Methods 
 
2.1 Tissue Preparation 
Formalin fixed paraffin embedded human colon 
tissue blocks were obtained from the UCL Biobank 
(REC 15/YH/0311). For each tissue block 8 µm tissue 
sections were prepared for RS on stainless steel 
slides, described previously by our group[19]. All 
samples for RS were deparaffinated with xylene with 
four, five-minute baths prior to rehydration and 
downstream analysis. Dewaxed samples were stored 
at room temperature and were Raman-mapped 
within 24 hours of rehydration.  
For each sample prepared for RS contiguous 3 µm 
tissue sections were also cut for IHC and H&E 
staining. H&E staining was carried out using the 
appropriate standard protocol and IHC staining, 
deparaffination and antigen retrieval was performed 
on a Leica Bond III auto-immunostaining platform, 
using Leica Bond Polymer Refine Detection (Leica 
DS9800) with DAB chromogen. The fully-automated 
system was run under optimal conditions for each 
antibody, as determined by positive controls. 
Primary antibodies were applied for 15 minutes at 
room temperature. Ki-67 antibody (Dako mouse 
clone MIB-1, M7240) was used at a dilution of 1/120 
and epitope retrieval performed in Leica ER2 
solution for 20 minutes at 99°C. Desmin antibody 
(Leica mouse clone DE-R-11, PA0032) was used as 
per manufacturer’s protocol and antigen retrieval 
performed in Leica ER2 solution for 20 minutes at 
99°C. Anti-MUC2 (Leica mouse clone Ccp58, NCL-
MUC-2) was applied at a dilution of 1/200 and 
epitopes retrieved in Leica ER2 solution for 30 
minutes at 99°C. Collagen III antibody (GeneTex 
mouse clone FH-7A, GTX26310) was applied at a 
dilution of 1/500 and epitope retrieval was carried 
out in Leica ER1 solution for 30 minutes at 99°C. 
Finally, anti-CD20 (Dako mouse clone L26, M0755) 
staining was performed at a dilution of 1/100 and 
epitope retrieval performed in ER1 solution for 20 
minutes, also at 99°C. 
 
2.2 Raman Measurement 
A Renishaw RA800 series benchtop Raman system 
configured for pathology use was used for all 
measurements. The instrument is configured with a 
1500 lines per mm diffraction grating, 785 nm laser 
excitation wavelength, a 50x, NA 0.75 objective and 
a motorized XYZ stage. The system is capable of 
imaging in transmitted and reflected white light 
mode for sample identification on both transparent 
and opaque substrates. StreamLine™ Raman 
imaging, a fast mapping method, was used for 
spectral collection. The spectral resolution was 2.5 
cm-1 and data was collected between 150-2100 cm-1. 
Fully-automated spectral alignment and calibration 
routines were in operation to ensure data 
reproducibility. Spectral collection was controlled by 
WiRE 4.0 software (Renishaw PLC). Raman maps 
were collected at an acquisition time of 0.3 seconds 
per pixel at 1.05 µm step size. Spectra were collected 
with a laser power of 230 mW measured at the 
sample. 
Pre-processing of raw spectra included cosmic ray 
removal and baseline correction using WiRE 4.0. 
Principal component analysis (PCA), also performed 
in WiRE 4.0 software, was then used for spectral 
data reduction and visualization. PCA was applied to 
the entire spectral region and spectra were mean 
centered and normalized by standard normal variate 
normalization. Spectral data was reduced to ten key 
components that explained the majority of the 
variance in the data. These components were used 
to plot pseudo-color images, which were created by 
applying a color weighting to the loadings of 
principal components from the spectral datasets. 
The resulting image displays the relative intensity of 
each component and its spatial distribution across 
the mapped region, and therefore in the sampled 
tissue.   
 
3 Results and Discussion 
Normal colon sections with easily distinguishable 
tissue morphology were selected for analysis in this 
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proof of concept study (Figure 1). Areas covering 
longitudinal crypt sections were selected for Raman 
mapping in contiguous sections since these 
contained discernable tissue features that could be 
easily compared to Raman data in the initial stages. 
The outermost structure of the colon consists of the 
lumen, which forms the tubular space inside the 
colon. Next, the mucosal layers makeup the inner 
lining of the colonic tissue and consists of the 
epithelium, a layer of connective tissue called the 
lamina propria and a layer of thin muscle, the 
muscularis mucosa. The colonic crypts are found 
within the mucosal layer in normal, healthy colon 
and contain a base of stem cells and are also lined 
with mucus secreting cells, amongst other cell types. 
Tissue maps were generated using Raman 
spectroscopy and corresponding tissue sections 
stained with the antibody panel; anti-Ki-67, anti-
desmin and anti-MUC2. Antibody stained tissue 
appears brown due to the DAB reaction and cell 
nuclei are counterstained blue/violet with 
hematoxylin, which binds to lysine residues localized 
to nuclear histones. 
Raman spectroscopy provides a biological 
‘fingerprint’ of the specimen under investigation 
between 450 – 2000 cm-1 and specific regions of the 
spectrum can be used to confirm the presence of 
various tissue components. Most notably, bond 
vibrations attributed to proteins at 1500 –1700 cm-1, 
carbohydrates at 470 –1200 cm-1 and DNA at 980, 
1080 and 1240 cm−1 are all present in the 
spectrum[24, 25]. Additionally, higher frequency modes 
due to lipid-associated bond vibrations can be found 
at 2700 – 3500 cm-1 [25]. 
 
PCA is an unsupervised, multivariate analysis 
technique that reduces the variance of the spectral 
dataset into a set of components that explain the 
variance within the data set. Individual components 
can be more easily visualised in space and represent 
a combination of loadings derived from a mixture of 
spectral features that best describe each 
component. The majority of the variance in the 
spectral dataset is explained by the first component, 
and the fraction explained then decreases 
sequentially with each subsequent component. For 
us the first three components explained the majority 
of the variance in the dataset and were deemed 
most histologically relevant. 
 
 
Figure 1 H&E stained longitudinal section of a normal colon 
tissue sample outlining major tissue structures. The colonic 
lumen (L) is visible in the bottom left and a whole colonic 
crypt, from crypt opening (CO) to crypt base (CB), through 
crypt lumen (CL), is identified between arrows. The lamina 
propria (LP), a layer of connective tissue surrounding the 
crypts can also be identified. The submucosa (S) is 
orientated to the top right corner of the image and 
connects the mucosa to the muscularis propria.  The 
muscularis mucosa (MM) is a thin layer of muscle 
separating crypt bases and the submucosa. Blood vessel 
(BV).      
Anti-desmin binds to desmin, a filament protein 
localized to muscle fibers that is responsible for 
connecting myofibrils to one another and to the 
plasma membrane. We observe intense anti-desmin 
staining localized to the muscularis mucosae, a thin 
layer of muscle that can be seen running along the 
crypt base. Staining of the plasma membrane on 
stromal cells, likely pericytes[26], outlining the 
boundaries of crypt structures can also be seen[27]. 
Fundamentally, the corresponding Raman map 
created using the PC1 loading shows good 
correlation to the staining density obtained with 
anti-desman IHC. Again, the muscularis mucosae has 
the highest Raman signal and signals outlining the 
plasma membranes of individual cells are also 
visible. The major spectral contributions used to 
generate the PC1 red pseudo-color image can be 
attributed to amino acid scatter, which have easily 
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distinguishable spectra, even in complex biological 
samples[28]. Intense peaks corresponding to proline 
at 852 cm-1, phenylalanine at 1004 cm-1 and the CH2 
bending mode of proteins at 1449 cm-1 all indicate 
that protein scatter is the major contributor to 
PC1[29].  
Anti-Ki67 stains a large nuclear protein that is 
expressed during all active phases of the cell cycle 
and is an established marker of cell proliferation. We 
would therefore expect the distribution of this stain 
to be localized to cell nuclei and to be of highest 
intensity towards the crypt base as this is where the 
cells are documented to be proliferating most 
rapidly. Figures 2 and 3 verifies this observation; the 
most intense anti-Ki67 staining is localized to crypt 
bases, with minor staining also found along the 
epithelium where cells are also dividing. The pseudo-
color Raman comparison (created from the PC2 
loading in the Principal Component Analysis) arises 
from DNA/RNA signals. Peaks characteristic of DNA 
have previously been assigned at 782 cm-1, 1100 cm-
1, 1335 cm-1, 1573 cm-1 and 1662 cm-1 [29] and 
corresponding peaks in the loadings of PC2 could be 
found at 780 cm-1 and 1105 cm-1 in our spectra. Even 
though the major peak in the loading identified 
around 556 cm-1 could not be assigned to DNA, the 
IHC/RS comparison for the Ki67 marker shows good 
correlation with DNA since the greatest scattering 
intensity is also mapped to crypt bases, where cells 
are actively proliferating. The same image also 
shows nucleotide scatter along crypt epithelium 
where cells are also growing, although to a lesser 
extent than at the crypt base. Variation in cellular 
DNA content is associated with different phases of 
the cell cycle[30]. RS is capable of identifying 
nucleotide signals and a major component identified 
in the spectral dataset could be related to nucleotide 
scatter; it is this component that was used to 
generate the pseudo-color (green) image for 
comparison against the Ki67 stain.  
 
MUC2 is the major mucin localized to the colon, 
more specifically to colonic crypts and the lumen. It 
is likely that some mucus remains trapped within the 
lumen of the crypt structures and within goblet cells 
following sample processing. Therefore, anti-MUC2 
was used to check for the presence of the 
glycoprotein. It is useful to be able to identify the 
localization of mucins in different pathologies since 
abnormal expression of these highly-glycosylated 
proteins can signal abnormalities. As expected, the 
antibody intensely stained the lumen of colonic 
crypts and the mucin secretory cells that line them. 
Since mucins are highly decorated with 
oligosaccharides, the major spectral component 
used to explore the distribution of mucins was based 
on glycan scatter in the tissue spectra. The blue 
distribution in the pseudo-color RS image (PC3 
loading) also indicates the presence of mucin in the 
secretory cells lining the crypt epithelium and in the 
crypt lumen. Alongside several protein peaks 
identified in the loadings of PC3, a peak at 440 cm-1 
and a considerable scatter in the low wavenumber 
region is seen to dominate PC3. Raman scatter in the 
low wavenumber region (450 – 650 cm-1) can be 
attributed to δ(C-O-C) found in glycosidic linkages 
of carbohydrates[31], which are found attached to 
mucins. Furthermore, since it is known that mucins 
are decorated with sulfate groups and that they 
form disulfide bond stabilized networks via 
cysteine resides, then S-S stretching modes arising 
at 498 cm-1, 512 cm-1 and 529 cm-1[32] are most 
likely contributing to the loadings on PC3. 
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Figure 2 Alternating Raman maps (left) and IHC images (right) of colon section showing crypt structures. Red Raman map 
indicates the distribution of muscle fibers and is correlated to anti-desmin, a muscle-specific antibody. Green Raman map 
highlights the distribution of DNA and is correlated to anti-Ki67 staining for proliferating cells. The blue Raman map shows the 
distribution of mucin glycoproteins in colonic crypts and this correlates to anti-muc6 staining in the IHC image. Scale bar is 50 
µM. Right hand panels display the loadings of the first three principal components identified by PCA with major peaks labelled. 
Percentage variance explained by individual components: PC1 = 40.0; PC2 = 21.5; PC3 = 5.4. 
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indicates the distribution of muscle fibers and is correlated to anti-desmin, a muscle-specific antibody. Green Raman map 
highlights the distribution of DNA and is correlated to anti-Ki67 staining for proliferating cells. The blue Raman map shows the 
distribution of mucin glycoproteins in colonic crypts and this correlates to anti-muc6 staining in the IHC image. Scale bar is 50 
µM. Right hand panels display the loadings of the first three principal components identified by PCA with major peaks labelled. 
Percentage variance explained by individual components: PC1 = 61.7; PC2 = 7.3; PC3 = 3.6. 
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There is good correlation between the spatial 
distributions of components in both tissue 
specimens studied. This was to be expected since 
the first set of components are most likely to map to 
protein and DNA, making these molecular species 
particularly easy to discriminate by PCA[33]. Although 
the distribution of protein and DNA are easily 
identified via this method, it is likely that other 
components that scatter less intensely will require 
more sophisticated multivariate analysis methods in 
order to identify their presence and distribution in 
relation to IHC markers. Additionally, although the 
first three components distinguish between protein, 
DNA and mucin, it should be noted that the loadings 
of components between tissue samples are not 
entirely comparable, which is particularly true for 
PC3. It is likely that spectral contamination due to 
fluorescence and paraffin retention are the cause of 
these inconsistencies in the loadings. Paraffin 
retention can contaminate Raman spectra across the 
whole biological region, masking peaks of interest 
and detrimentally contributing to PC loadings; 
particularly those associated with discriminating 
lipids[29, 33]. Additionally, mucin-related signals will be 
highly influenced by paraffin since we have observed 
that it is commonly retained in mucus and that the 
vigorous deparaffination required to remove 
trapped paraffin sometimes also removes the non-
attached mucus layer. It is therefore important that 
future studies implement careful yet vigorous 
methods to remove paraffin from sections prior to 
analysis so that these signals do not interfere with 
the identification of low abundance species or alter 
the native lipid and mucin component of the sample. 
To highlight the capabilities of Raman in 
multiplexing, we mapped the distributions of 
multiple components onto a single tissue map. The 
first five components from figure 2 were 
superimposed onto figure 4, with additional 
components that localized to lipids and vasculature 
(identified by characteristic lipid-associated Raman 
scatter attributed to C=C stretch at 1654 cm-1 [34] in 
spectral loadings). In the multiplexed, pseudo-color 
image, individually colored components clearly 
indicate the distributions of various morphological 
features and tissue and cellular subtypes and these 
can all be identified from spectra collected during a 
single experimental run. The distribution of muscle 
tissue, DNA, mucus glycoproteins and lipids can all 
be seen and there is an obvious greater wealth of 
information in the Raman
 
Figure 4 Raman false colour map (left) compared alongside a standard H&E stained section that reveals only cytoplasmic and 
nuclear distributions (right). Raman map shows several biochemical components on same section with each color representing 
the spatial distribution of a specific biochemical component, ranging from DNA (green) to muscle fibers (red), lipids (yellow) and 
mucin glycoproteins (blue) as detailed in Figure 2. Scale bar is 50 µM. 
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map, at least comparable to that achievable with 
multi-antigen IHC compared to the corresponding 
conventional H&E section, which provides only basic 
morphological detail regarding the localization of cell  
nuclei and cytoplasmic regions. The colonic crypts 
can be easily visualized in the H&E stained section, 
but there is no indication of mucus presence and 
vasculature is more difficult to distinguish.     
On the multiplexed image, as expected, PCA was 
able to distinguish musculature from vascular and 
connective tissue since muscle fibers are 
predominantly comprised of actin and myosin 
proteins. Both actin and myosin possess secondary 
structures rich in alpha helices, which give 
characteristic Raman scatter, and these are 
dissimilar to the spectral patterns obtained from 
collagen, which contains high concentrations of 
glycine in an ordered type-2 helix, hydroxyproline 
(an amino acid rare in other proteins) and a triple 
helical structure. The presence of blood vessels can 
be distinguished, albeit at low contrast, in the H&E 
stained section, however the yellow component 
attributed to lipids in the pseudo-color image cannot 
be seen. The co-localization of Ki-67 staining and 
DNA signal obtained using RS to cells lining the 
colonic crypts was also anticipated. Previous work 
has identified that proliferative cells have distinct 
Raman spectra based on the conformation of DNA 
during various phases of the cell cycle. Since the 
most active, proliferating cells are found adjacent to 
the crypt base (where the colonic stem cells reside) 
and lining the colonic epithelium, we would expect 
an overlap of signals in these tissue regions. All cell 
nuclei can be easily distinguished in the H&E image 
since DNA is densely stained violet with hematoxylin. 
There is good correlation between the well-
established hematoxylin stain for DNA and the DNA 
Raman scatter, which indicates the reliability of the 
Raman signal; strong Raman and dye intensities can 
be seen in crypt bases and along the epithelium 
lining the crypts. Importantly all of these individual 
components have been identified in a single Raman 
map, using one tissue section, proving the 
multiplexing capabilities of RS and directly 
correlating them to the “ground truth” of known IHC 
and H&E markers. Routinely using RS in this manner 
would minimize the usage of expensive antibodies 
and reduce the number of tissue sections required 
for pathologists to reach a diagnosis, since multiple 
components could be identified in a single piece of 
tissue. Multiplexing would also save time and reduce 
the burden on healthcare staff. The non-destructive 
nature of RS also offers the possibility of returning 
the sample to the conventional downstream analysis 
pathway and investigation with conventional 
methods after the tissue has been mapped, which is 
not possible following IHC or H&E staining. 
4 Conclusion 
This proof-of-concept study has demonstrated that 
RS is capable of providing complimentary 
information to IHC for anatomical regions based on 
tissue-subtyping. The capabilities of RS to detect 
chemical signatures and to provide predictive 
models of disease using these signatures is 
already well documented. However, previous 
studies of this kind are rarely confirmed by 
secondary methods, whereas this study 
validates the use of RS in the detection of cell 
and tissue subtyping since the correct tissue 
signals could be mapped to clinically validated 
IHC markers. We show that mucins can be easily 
distinguished due to their rich glycosylation, 
nuclear regions by their DNA content and 
various other tissue types can be identified 
based on differences in amino acid content and 
structural conformation, as is the case with 
muscle fibers and collagen found in connective 
tissue. There is a vast and growing catalogue of 
non-validated RS tissue signatures already 
reported in the literature and, like our limited 
dataset, these should also be verified using 
complementary analytical methods, such as 
MALDI imaging and IHC. Without this link to the 
ground truth established by IHC or other 
molecular techniques the assignment of 
spectral signatures to discrete tissue and 
cellular subtypes through subjective inspection 
alone will remain speculative and loosely 
correlated. Future studies should also include 
spectra and corresponding markers from cell lines, in 
order to confirm the identification of cell type by RS. 
This article is protected by copyright. All rights reserved.
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